Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H13NO3S |
| Molecular Weight | 179.237 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)NC1CCCCC1
InChI
InChIKey=HCAJEUSONLESMK-UHFFFAOYSA-N
InChI=1S/C6H13NO3S/c8-11(9,10)7-6-4-2-1-3-5-6/h6-7H,1-5H2,(H,8,9,10)
| Molecular Formula | C6H13NO3S |
| Molecular Weight | 179.237 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.fda.gov/downloads/food/ingredientspackaginglabeling/foodadditivesingredients/ucm404344.pdfCurator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/10653518 |https://www.ncbi.nlm.nih.gov/pubmed/22579423
Sources: https://www.fda.gov/downloads/food/ingredientspackaginglabeling/foodadditivesingredients/ucm404344.pdf
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/10653518 |https://www.ncbi.nlm.nih.gov/pubmed/22579423
Cyclamic acid (Cyclamate) is banned in the United States but it is used in many other Western countries without safety concerns. Cyclamate interacts with the sweet taste receptor subunit T1R3 transmembrane domain. Initially it was recommended for use in treatment of obese patients and by individuals with diabetes but in August 27, 1970 FDA concluded that there was no substantial evidence of effectiveness of cyclamate compounds at any level for treatment of obese patients and individuals with diabetes and therefore prohibited continued sale of cyclamate containing products with drug labeling. cyclamate is the putative carcinogenic agent. Cyclamate was tested in the Maximal Electroshock Seizure model (mice, ip), showing moderate anticonvulsant activity.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: 83756.0 Gene Symbol: TAS1R3 |
3.1 mM [EC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Sucaryl Approved UseUnknown Launch Date1952 |
|||
| Primary | Sucaryl Approved UseUnknown Launch Date1952 |
|||
| Primary | Unknown Approved UseUnknown |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
400 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1379387/ |
2.2 g 3 times / day steady-state, oral dose: 2.2 g route of administration: Oral experiment type: STEADY-STATE co-administered: |
CYCLOHEXYLAMINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1912 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1379387/ |
2.2 g 3 times / day steady-state, oral dose: 2.2 g route of administration: Oral experiment type: STEADY-STATE co-administered: |
CYCLOHEXYLAMINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1379387/ |
2.2 g 3 times / day steady-state, oral dose: 2.2 g route of administration: Oral experiment type: STEADY-STATE co-administered: |
CYCLOHEXYLAMINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of artificial sweeteners on body weight, food and drink intake. | 2010-12 |
|
| [Simultaneous determination of six synthetic sweeteners in food by high performance liquid chromatography-tandem mass spectrometry]. | 2010-11 |
|
| Retention behaviour of some high-intensity sweeteners on different SPE sorbents. | 2010-10-15 |
|
| Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor. | 2010-08-02 |
|
| Sensory quality of functional beverages: bitterness perception and bitter masking of olive leaf extract fortified fruit smoothies. | 2010-08-01 |
|
| [Determination of five synthetic sweeteners in wines using high performance liquid chromatography-tandem mass spectrometry]. | 2010-08 |
|
| Chronic consumption of fructose rich soft drinks alters tissue lipids of rats. | 2010-06-23 |
|
| Gain weight by "going diet?" Artificial sweeteners and the neurobiology of sugar cravings: Neuroscience 2010. | 2010-06 |
|
| Performance of conventional multi-barrier drinking water treatment plants for the removal of four artificial sweeteners. | 2010-06 |
|
| Responses of single chorda tympani taste fibers of the calf (Bos taurus). | 2010-06 |
|
| Key amino acid residues involved in multi-point binding interactions between brazzein, a sweet protein, and the T1R2-T1R3 human sweet receptor. | 2010-05-14 |
|
| Positive allosteric modulators of the human sweet taste receptor enhance sweet taste. | 2010-03-09 |
|
| Tailored adsorption of His6-tagged protein onto nickel(II)-cyclam grafted mesoporous silica. | 2010-02-21 |
|
| Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists. | 2010-02-01 |
|
| An attempt to use sweeteners as a material for accident dosimetry. | 2010-02 |
|
| Anionic leak currents through the Na+/monocarboxylate cotransporter SMCT1. | 2010-01 |
|
| Evaluation of certain food additives. Seventy-first report of the Joint FAO/WHO Expert Committee on Food Additives. | 2010 |
|
| Sugar alcohols, caries incidence, and remineralization of caries lesions: a literature review. | 2010 |
|
| Genetic and molecular basis of individual differences in human umami taste perception. | 2009-08-21 |
|
| A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis. | 2009-08-12 |
|
| Analysis and occurrence of seven artificial sweeteners in German waste water and surface water and in soil aquifer treatment (SAT). | 2009-07 |
|
| Development and single-laboratory validation of an HPLC method for the determination of cyclamate sweetener in foodstuffs. | 2009-05 |
|
| Determination of nine intense sweeteners in foodstuffs by high-performance liquid chromatography and evaporative light-scattering detection: interlaboratory study. | 2009-04-23 |
|
| Simultaneous determination of nonnutritive sweeteners in foods by HPLC/ESI-MS. | 2009-04-22 |
|
| Magnetic behaviour of nickel-cyclam complexes in mesoporous silica: EPR investigations. | 2009-02-18 |
|
| Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. | 2009 |
|
| Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation. | 2008-12-19 |
|
| The capsaicin receptor participates in artificial sweetener aversion. | 2008-11-28 |
|
| Determination of cyclamate in foods by ultraperformance liquid chromatography/tandem mass spectrometry. | 2008-11-05 |
|
| Spanish Ketogenic Mediterranean Diet: a healthy cardiovascular diet for weight loss. | 2008-10-26 |
|
| Simultaneous square-wave voltammetric determination of aspartame and cyclamate using a boron-doped diamond electrode. | 2008-07-30 |
|
| Catalyzed oxidative corrosion of porous silicon used as an optical transducer for ligand-receptor interactions. | 2008-07-21 |
|
| [Compound preservative and cyclamat determinated by gas chromatography]. | 2008-07 |
|
| Direct NMR detection of the binding of functional ligands to the human sweet receptor, a heterodimeric family 3 GPCR. | 2008-06-11 |
|
| Estimated intake of intense sweeteners from non-alcoholic beverages in Denmark, 2005. | 2008-06 |
|
| Chemical carcinogenesis studies in nonhuman primates. | 2008 |
|
| The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor. | 2007-10-12 |
|
| Influence of artificial sweetener on human blood glucose concentration. | 2007-10-05 |
|
| Influence of artificial sweeteners on the kinetic and metabolic behavior of Lactobacillus delbrueckii subsp. bulgaricus. | 2007-10 |
|
| Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes. | 2007-10 |
|
| Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor. | 2007-09-14 |
|
| Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. | 2007-09 |
|
| Artificial sweeteners and salts producing a metallic taste sensation activate TRPV1 receptors. | 2007-08 |
|
| Simultaneous determination of nine intense sweeteners in foodstuffs by high performance liquid chromatography and evaporative light scattering detection--development and single-laboratory validation. | 2007-07-20 |
|
| Rapid determination of cyclamate in foods by solid-phase extraction and capillary electrophoresis. | 2007-06-22 |
|
| [Restless legs due to ingestion of 'light' beverages containing saccharine. Results of an N-of-1 trial]. | 2007-06 |
|
| Structures of artificial sweeteners--cyclamic acid and sodium cyclamate with other cyclamates. | 2007-06 |
|
| A conductive pathway generated from fragments of the human red cell anion exchanger AE1. | 2007-05-15 |
|
| Estimated intake of intense sweeteners from non-alcoholic beverages in Denmark. | 2007-03 |
|
| [Optimization of preparative technique for banxia-houpu effervescent tablets by orthogonal design]. | 2006-10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.fda.gov/downloads/food/ingredientspackaginglabeling/foodadditivesingredients/ucm404344.pdf
Curator's Comment: It is unnecessary to decide the acceptable daily intake and safe conditions for use issues.
5 mg cyclamate/kg bodyweight/day or less
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2416656
The addition of sodium cyclamate (75 mM) to the culture of the native bacterial population of the caecum concurrent with the progressive dilution of the growth medium promoted metabolism of cyclamate to cyclohexylamine (sulphamatase activity) within 4 wk. The maximum formation of cyclohexylamine was attained in about 8 wk and was equivalent to a 2-3% molar conversion of cyclamate to cyclohexylamine.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:55:27 GMT 2025
by
admin
on
Mon Mar 31 17:55:27 GMT 2025
|
| Record UNII |
HN3OFO5036
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 189.135
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
||
|
JECFA EVALUATION |
INS-952(I)
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
||
|
NCI_THESAURUS |
C283
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
||
|
EPA PESTICIDE CODE |
271200
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7533
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
C76514
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
HN3OFO5036
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
2969
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB13513MIG
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
202-898-1
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
275
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
CHEMBL1206440
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
1152600
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
100000079489
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
INS-952(I)
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | CYCLAMATES | ||
|
CYCLAMIC ACID
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
100-88-9
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
HN3OFO5036
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
220327
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
DTXSID5041809
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | |||
|
m3966
Created by
admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
|
||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |